Meta Pixel

News and Announcements

Debunking the Top 3 Myths About Raising Capital

  • Published August 31, 2023 1:19AM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

Raising capital is a journey filled with challenges and opportunities. As a founder, director, or CEO, understanding the process is crucial to successfully navigate this journey. Today, let’s debunk three common myths about raising capital and provide valuable insights based on real-world experiences.

YouTube player

Myth 1: Raising Capital Only Takes 2-3 Months

The first myth is that raising capital only takes two to three months. In reality, it can take anywhere from six months to 18 months. Capital raising takes time and often involves a significant amount of behind-the-scenes work. It’s not uncommon for companies to work on a capital raise for up to a year before closing the deal.

Myth 2: Advisors Use Sophisticated Analytical Tools

The second myth is that corporate advisors and investment banks use sophisticated analytical tools for their transactions. However, many companies and advisors use simple tools like Excel spreadsheets and emails for their transactions. The use of analytics in the capital raising process is crucial, and companies should have visibility over who is involved and what is happening inside the deal room.

Myth 3: VCs are the Main Investors

The third myth is that venture capitalists (VCs) are the main investors in this space. While VCs play a significant role, they are not the only investors. High net worth family offices and industry participants are often the main investors in this space. There are many different investment groups that operate outside of the VC structure.

In conclusion, raising capital is a journey that involves different stages, each with its own set of challenges. Understanding these stages can help you better navigate the capital raising process and increase your chances of success. Remember, every stage of your business, from ideation to pre-IPO, presents unique opportunities to attract investment and drive growth. Embrace these challenges, learn from them, and keep moving forward on your capital raising journey.

Capital Insights
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t

The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.

Capital Insights
Following the Billions: Where the Hyperscalers are Betting on the Future

The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.

Join over 45,000+ sophisticated investors

Join Now